The Efficacy And Safety Of Broad-Spectrum Antibiotics For Rhinosinusitis: A Systematic Review For Outpatient Patients
Abstract
The debate surrounding antibiotic use in acute rhinosinusitis is ongoing, with 85% of cases being viral and 40% being chronic. Antibiotics are more effective than placebo for purulent nasal discharge and discolored mucus, and trials comparing antibiotics with placebo and the right antibiotics are needed to reduce unnecessary prescriptions while ensuring efficacy. Acute rhinosinusitis is one of the most common infections in the United States, accounting for 2% of ambulatory care visits and costing approximately $500 million for treatment with antibiotics. A recent report from the National Ambulatory Medical Care Survey showed an increased monotherapy antibiotic use for rhinosinusitis from 31% in 1990-1992 to 84% in 1999. Ninety percent of the antibiotics used were broad-spectrum ones. Subacute rhinosinusitis occurs in 0.5-2% of cases. 85% of the 200,000 sinus surgical procedures in the US are due to acute rhinosinusitis. This review aims to address controversies on antibiotic use in acute rhinosinusitis by focusing on high-quality studies to comprehensively assess the efficacy and safety of broad-spectrum antibiotics in the treatment of acute rhinosinusitis. A thorough search of multiple reputable databases will be conducted, extracting data from each study regarding the study design, sample size, duration of treatment, follow-up period, primary and secondary outcomes, and any adverse events. The Cochrane Risk of Bias Tool will be used to assess the methodological quality of…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.